Lexicon Pharmaceuticals (LXRX)

• Market cap: $487M
• 1 day: 0.75%
• 5 days: -5.63%
• 1 month: -0.74%
• 3 months: 31.37%
• 6 months: 83.36%
• Year to date: 72.44%
• 1 year: -31.28%
• 5 years: 20.72%
• 10 years: -85.91%
• Sector: Healthcare
• Industry: Biotechnology

About: Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

Employees: 103